Nymox Pharmaceutical
NYMX
#9795
Rank
S$24.65 M
Marketcap
Country
$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.82 Million, an increase over its 2021 earnings that were of -S$16.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-65.62%
2022 -S$8.82 Million-47.71%
2021 -S$16.86 Million6.61%
2020 -S$15.82 Million-10.91%
2019 -S$17.75 Million24.24%
2018 -S$14.29 Million-20.03%
2017 -S$17.87 Million2.71%
2016 -S$17.4 Million-63.86%
2015 -S$48.13 Million674.44%
2014 -S$6.22 Million-6.11%
2013 -S$6.62 Million-35.66%
2012 -S$10.29 Million-20.76%
2011 -S$12.99 Million38.33%
2010 -S$9.39 Million35.59%
2009 -S$6.93 Million11.8%
2008 -S$6.2 Million-12.94%
2007 -S$7.12 Million8.85%
2006 -S$6.54 Million36.5%
2005 -S$4.79 Million-4.4%
2004 -S$5.01 Million-14.58%
2003 -S$5.87 Million
2001 -S$4.31 Million-20.54%
2000 -S$5.42 Million21.72%
1999 -S$4.45 Million-25.56%
1998 -S$5.98 Million101.3%
1997 -S$2.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.15 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.37 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.50 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.71 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.84 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA